Cellular & Metabolic Compounds
AOD-9604
2mgC₇₈H₁₂₃N₂₃O₂₃S₂
Key Research Findings
- Characterisation of the modified hGH 176–191 fragment.
- Published in-vitro adipocyte lipolysis assay data.
- IGF-1-receptor non-binding profile reported in receptor-affinity studies.
Overview
AOD-9604 is a synthetic modified fragment of the C-terminal sequence of human growth hormone (hGH 176–191). Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro adipocyte assays as a fragment active on lipolysis-related enzyme pathways without IGF-1-receptor binding. Not intended for human or veterinary use.
Research Effects
Adipocyte Lipolysis Assays
Extensive ResearchReported in in-vitro adipocyte cell-line assays as active on lipolysis-related enzyme pathways.
IGF-1 Receptor Profile
Moderate ResearchReceptor-affinity studies report no binding of IGF-1 receptor under assay conditions tested.
Chondrogenic Cell Studies
Preliminary ResearchEarly-stage in-vitro studies on chondrocyte cell models.
Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.
Quick Facts
Research Status Key
Related Peptides
Cellular & Metabolic Compounds
MOTS-C
MOTS-c is a 16 amino acid peptide encoded not in nuclear DNA but within the mitochondrial 12S ribosomal RNA gene, making it one of a small group of mitochondrial-derived peptides identified since 2015. Its discovery is relatively recent, so the literature is smaller than for the older research peptides in this catalogue, but it is growing quickly and comes from mainstream metabolic research groups rather than from a single laboratory. We supply it as a lyophilised powder at 10mg per vial with an independent batch certificate of analysis reporting HPLC purity and mass spectrometry identity.
Learn More →
Cellular & Metabolic Compounds
HGH-Frag 176-191
HGH-Fragment 176–191 is a synthetic stabilised analogue of the C-terminal 176–191 sequence of human growth hormone. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →